Shivshankari Rajkumar

850 total citations · 1 hit paper
7 papers, 464 citations indexed

About

Shivshankari Rajkumar is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Shivshankari Rajkumar has authored 7 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Shivshankari Rajkumar's work include Melanoma and MAPK Pathways (5 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Shivshankari Rajkumar is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Shivshankari Rajkumar collaborates with scholars based in Canada, United States and India. Shivshankari Rajkumar's co-authors include Ian R. Watson, Matthew Dankner, Peter M. Siegel, April A. N. Rose, Mathieu Lajoie, Alexei Protopopov, Xiu Huang, Morag Park, Marie‐Christine Guiot and Kevin Petrecca and has published in prestigious journals such as Oncogene, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Shivshankari Rajkumar

7 papers receiving 456 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations

2018 348 citations Matthew Dankner, April A. N. Rose et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shivshankari Rajkumar Canada	5	310	231	123	114	82	7	464
Julien Bollard France	8	241 0.8×	217 0.9×	76 0.6×	120 1.1×	60 0.7×	16	457
Xueqian Gong United States	8	304 1.0×	294 1.3×	97 0.8×	214 1.9×	89 1.1×	16	581
Kelly E. Fisher United States	4	434 1.4×	288 1.2×	91 0.7×	76 0.7×	80 1.0×	6	599
Shonda M Little United States	7	316 1.0×	424 1.8×	168 1.4×	122 1.1×	114 1.4×	10	549
Lysiane Huber United States	6	273 0.9×	216 0.9×	81 0.7×	86 0.8×	31 0.4×	11	393
Lany Ruslim United States	6	308 1.0×	155 0.7×	83 0.7×	86 0.8×	39 0.5×	6	514
Elisabeth Llonch Switzerland	2	509 1.6×	214 0.9×	106 0.9×	128 1.1×	93 1.1×	2	651
Zoi Karoulia United States	6	560 1.8×	238 1.0×	130 1.1×	85 0.7×	58 0.7×	9	664
Chenjing Xia China	4	439 1.4×	308 1.3×	74 0.6×	52 0.5×	49 0.6×	9	538
Heidi Simmons United States	4	446 1.4×	296 1.3×	87 0.7×	64 0.6×	57 0.7×	11	596

Countries citing papers authored by Shivshankari Rajkumar

Since Specialization

Citations

This map shows the geographic impact of Shivshankari Rajkumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shivshankari Rajkumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shivshankari Rajkumar more than expected).

Fields of papers citing papers by Shivshankari Rajkumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shivshankari Rajkumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shivshankari Rajkumar. The network helps show where Shivshankari Rajkumar may publish in the future.

Co-authorship network of co-authors of Shivshankari Rajkumar

This figure shows the co-authorship network connecting the top 25 collaborators of Shivshankari Rajkumar. A scholar is included among the top collaborators of Shivshankari Rajkumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shivshankari Rajkumar. Shivshankari Rajkumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Rajkumar, Shivshankari, LeeAnn Ramsay, Mathieu Lajoie, et al.. (2022). Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy. Cell Reports. 39(1). 110634–110634. 16 indexed citations

2.

Shorstova, Tatiana, Jie Su, Tiejun Zhao, et al.. (2020). Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition. Molecular Cancer Therapeutics. 20(1). 64–75. 9 indexed citations

3.

Dankner, Matthew, Mathieu Lajoie, Dan Moldoveanu, et al.. (2018). Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas. Clinical Cancer Research. 24(24). 6483–6494. 47 indexed citations

4.

Dankner, Matthew, April A. N. Rose, Shivshankari Rajkumar, Peter M. Siegel, & Ian R. Watson. (2018). Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations. Oncogene. 37(24). 3183–3199. 348 indexed citations breakdown →

5.

Rose, April A. N., Matthew Dankner, Shivshankari Rajkumar, et al.. (2018). Abstract B056: Non-V600 BRAF mutations in melanoma: actionable targets for rational drug combinations. Molecular Cancer Therapeutics. 17(1_Supplement). B056–B056. 1 indexed citations

6.

Desai, Nirav K., et al.. (2018). Natural Killer Cells: From Defense to Immunotherapy in Cancer. Journal of Stem Cell Research & Therapy. 8(3). 2 indexed citations

7.

Rajkumar, Shivshankari & Ian R. Watson. (2016). Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies. British Journal of Cancer. 115(2). 145–155. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact